Amdocs (NASDAQ:DOX) Releases FY 2025 Earnings Guidance

Amdocs (NASDAQ:DOX) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 6.859-7.116 for the period, compared to the consensus earnings per share estimate of 6.970. The company issued revenue guidance of $4.4 billion-$4.6 billion, compared to the consensus revenue estimate of $4.5 billion. Amdocs also updated its Q2 2025 guidance to 1.670-1.730 EPS.

Amdocs Trading Down 1.8 %

Shares of DOX traded down $1.58 during midday trading on Wednesday, reaching $85.28. The company had a trading volume of 131,770 shares, compared to its average volume of 550,295. Amdocs has a 1-year low of $74.41 and a 1-year high of $94.04. The stock has a market cap of $9.63 billion, a PE ratio of 20.11, a price-to-earnings-growth ratio of 1.47 and a beta of 0.71. The firm has a 50 day simple moving average of $85.96 and a 200-day simple moving average of $86.40. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.69% and a net margin of 9.85%. Research analysts forecast that Amdocs will post 6.19 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Tuesday, December 31st were issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date was Tuesday, December 31st. Amdocs’s dividend payout ratio (DPR) is 45.28%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Barclays cut their price target on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research report on Thursday, November 14th. Finally, Oppenheimer boosted their target price on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and an average target price of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.